1Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [ J ].Hepatology, 1996,23( 1 ) : 164 - 176.
2Runyon BA. Care of patients with ascites[ J]. N Engl J Med, 1994, 330 ( 5 ) : 337 - 342.
3Vinel JP, Denoyel P, Viossat I, et al. Atrial natriuretic peptide,plasma renin activity, plasma volume, systemic vascular resistance and cardiac output in patients with cirrhosis [ J ]. J Gastroenterol Hepatol, 1989,4 (6) : 529 - 535.
4Parlapiano C, Labellarte A, Primi F, et al. ANP in the cirrhotic patient. A clinical contribution [ J ]. Minerva Endocrinol, 1994, 19 (3): 121 -126.
5Gulberg V, Bilzer M, Gerbes AL. Long-term therapy and retreatment of hepatorenal syndrome type 1 with omipressin and dopamine [ J ]. Hepatology, 1999, 30:870 - 875.
6Pozzi M, Osculati G, Boari G, et al. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites [ J ]. Gastroenterology, 1994,106(3) : 709 - 719.
7Runyon BA. Management of adult patients with ascites caused by cirrhosis [ J ]. Hepatology, 1998,27 ( 1 ):264 -272.
8Gines A, Planas R, Angeli P, et al. Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic paracentesis [ J ]. Hepatology, 1995,22 (1): 124 -131.
9Gines A, Fernandez-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis [ J]. Gastroenterology, 1996,111 (4): 1002 - 1010.
10Altman C, Bernard B, Roulot D, et al. Randomized comparative muhicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis[ J]. Eur J Gastroenterol Hepatol, 1998,10:5 - 10.
